Korean J Ophthalmol.  2019 Oct;33(5):467-474. 10.3341/kjo.2019.0060.

Evaluation of the Protective Effect of an Ophthalmic Viscosurgical Device on the Ocular Surface in Dry Eye Patients during Cataract Surgery

• Yoon DY
• Kim JH
• Jeon HS
• Jeon HE
• Han SB
• Hyon JY

• KMID: 2459529
• DOI: http://doi.org/10.3341/kjo.2019.0060

Abstract

PURPOSE
To evaluate the protective effect of applying an ophthalmic viscosurgical device (OVD) to the ocular surface during cataract surgery and its ability to prevent dry eye syndrome.
METHODS
Twenty-four patients aged 50 to 75 years who underwent cataract surgery at Seoul National University Bundang Hospital and agreed to participate in the study were included and divided into two groups: a study group who underwent cataract surgery after application of an OVD to the ocular surface, and a control group who underwent cataract surgery without application of an OVD. DisCoVisc was used as the OVD in the study group, while other factors including surgical techniques and administration of anesthetic agents were performed in both groups in the same manner. Indicators of dry eye syndrome including ocular staining score, tear break-up time, and tear osmolality were analyzed. Ocular surface disease index and a visual analog scale were analyzed for dry eye symptoms, and the amount of balanced salt solution used during surface irrigation and operation time were also analyzed.
RESULTS
Significant improvement in the tear break-up time, corneal ocular staining score, and ocular surface disease index score in the study group compared with the control group one week after operation (by the Mann-Whitney test). Use of OVD was associated with longer operating time.
CONCLUSIONS
OVD applied to the ocular surface during cataract surgery had a protective effect on the ocular surface one week after surgery.

Keyword

Cataract extraction; Dry eye syndromes; Ophthalmic viscosurgical device

MeSH Terms

Anesthetics
Cataract Extraction
Cataract*
Dry Eye Syndromes
Humans
Osmolar Concentration
Seoul
Tears
Visual Analog Scale
Anesthetics

Figure

• 

  Fig. 1 Differences between preoperative and postoperative dry eye evaluation values at 1 week and 1 month after cataract. (A) Tear break-up time (BUT), (B) tear osmolality (Osm), (C) corneal ocular staining score (OSS), (D) conjunctival ocular staining score, (E) ocular surface disease index (OSDI), and (F) visual analog scale (VAS).

Reference

1. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009; 32:1–32.

2. Khanal S, Tomlinson A, Esakowitz L, et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthalmic Physiol Opt. 2008; 28:127–134.

3. Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea. 2007; 26:9 Suppl 1. S16–S20.

4. Hardten DR. Dry eye disease in patients after cataract surgery. Cornea. 2008; 27:855.

5. Szakats I, Sebestyen M, Toth E, Purebl G. Dry eye symptoms, patient-reported visual functioning, and health anxiety influencing patient satisfaction after cataract surgery. Curr Eye Res. 2017; 42:832–836.

6. Oh T, Jung Y, Chang D, et al. Changes in the tear film and ocular surface after cataract surgery. Jpn J Ophthalmol. 2012; 56:113–118.

7. Kato K, Miyake K, Kondo N, et al. Conjunctival goblet cell density following cataract surgery with diclofenac versus diclofenac and rebamipide: a randomized trial. Am J Ophthalmol. 2017; 181:26–36.

8. Sahu PK, Das GK, Malik A, Biakthangi L. Dry eye following phacoemulsification surgery and its relation to associated intraoperative risk factors. Middle East Afr J Ophthalmol. 2015; 22:472–477.

9. Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol. 2009; 23:65–73.

10. Shao D, Zhu X, Sun W, et al. Effects of femtosecond laser-assisted cataract surgery on dry eye. Exp Ther Med. 2018; 16:5073–5078.

11. Moon H, Yoon JH, Hyun SH, Kim KH. Short-term influence of aspirating speculum use on dry eye after cataract surgery: a prospective study. Cornea. 2014; 33:373–375.

12. Ram J, Gupta A, Brar G, et al. Outcomes of phacoemulsification in patients with dry eye. J Cataract Refract Surg. 2002; 28:1386–1389.

13. Kawahara A, Utsunomiya T, Kato Y, Takayanagi Y. Comparison of effect of nepafenac and diclofenac ophthalmic solutions on cornea, tear film, and ocular surface after cataract surgery: the results of a randomized trial. Clin Ophthalmol. 2016; 10:385–391.

14. Mohammadpour M, Mehrabi S, Hassanpoor N, Mirshahi R. Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: a randomized clinical trial. J Curr Ophthalmol. 2016; 29:33–38.

15. Zhao X, Xia S, Chen Y. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017; 96:e8174.

16. Ho JW, Afshari NA. Advances in cataract surgery: preserving the corneal endothelium. Curr Opin Ophthalmol. 2015; 26:22–27.

17. Giardini P, Hauranieh N, Gatto C, et al. Tripolymeric corneal coating gel versus balanced salt solution irrigation during cataract surgery: a retrospective analysis. Cornea. 2018; 37:431–435.

18. Hyon JY, Kim HM, Lee D, et al. Korean guidelines for the diagnosis and management of dry eye: development and validation of clinical efficacy. Korean J Ophthalmol. 2014; 28:197–206.

19. Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998; 17:38–56.

20. Whitcher JP, Shiboski CH, Shiboski SC, et al. A simplified quantitative method for assessing keratoconjunctivitis SICCA from the Sjogren’s Syndrome International Registry. Am J Ophthalmol. 2010; 149:405–415.

21. Liu Z, Luo L, Zhang Z, et al. Tear film changes after phacoemulsification. Zhonghua Yan Ke Za Zhi. 2002; 38:274–277.

22. Kasetsuwan N, Satitpitakul V, Changul T, Jariyakosol S. Incidence and pattern of dry eye after cataract surgery. PLoS One. 2013; 8:e78657.

23. Sajnani R, Raia S, Gibbons A, et al. Epidemiology of persistent postsurgical pain manifesting as dry eye-like symptoms after cataract surgery. Cornea. 2018; 37:1535–1541.

24. Walker TD. Benzalkonium toxicity. Clin Exp Ophthalmol. 2004; 32:657.

25. Hwang HB, Kim HS. Phototoxic effects of an operating microscope on the ocular surface and tear film. Cornea. 2014; 33:82–90.

26. Ipek T, Hanga MP, Hartwig A, et al. Dry eye following cataract surgery: the effect of light exposure using an in-vitro model. Cont Lens Anterior Eye. 2018; 41:128–131.

27. Kohlhaas M. Corneal sensation after cataract and refractive surgery. J Cataract Refract Surg. 1998; 24:1399–1409.

28. El Ameen A, Majzoub S, Vandermeer G, Pisella PJ. Influence of cataract surgery on Meibomian gland dysfunction. J Fr Ophtalmol. 2018; 41:e173–e180.

29. Han KE, Yoon SC, Ahn JM, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014; 157:1144–1150.

30. He Y, Li J, Zhu J, et al. The improvement of dry eye after cataract surgery by intraoperative using ophthalmic viscosurgical devices on the surface of cornea: the results of a consort-compliant randomized controlled trial. Medicine (Baltimore). 2017; 96:e8940.

31. Yusufu M, Liu X, Zheng T, et al. Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients. Int Ophthalmol. 2018; 38:1261–1273.

32. Gonzalez-Mesa A, Moreno-Arrones JP, Ferrari D, Teus MA. Role of tear osmolarity in dry eye symptoms after cataract surgery. Am J Ophthalmol. 2016; 170:128–132.

33. Xue W, Zhu MM, Zhu BJ, et al. Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. Int Ophthalmol. 2019; 39:419–429.